Corrigendum to: 'HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies' [Europace 2011;13:1077-109, doi: 10.1093/europace/eur245]
Michael J. Ackerman(Mayo Clinic), Douglas P. Zipes(Indiana University School of Medicine), Ramón Brugada(Institut d'Investigació Biomèdica de Girona), Silvia G. Priori(University of Pavia), Ray E. Hershberger(Bristol-Myers Squibb (United States)), A. John Camm(St George's, University of London), Christopher Semsarian(The University of Sydney), Christian Wolpert(Klinikum Ludwigsburg), Charles I. Berul(Children's National), Hugh Watkins(John Radcliffe Hospital), Michael H. Gollob(University of Toronto), R. Hamilton, Hugh Calkins, Hervé Le Marec(Centre National de la Recherche Scientifique), Eric Schulze‐Bahr(University of Münster), Patrick T. Ellinor(Broad Institute), Stephan Willems(Atrial Fibrillation NETwork), Daniel P. Judge(Medical University of South Carolina), Arthur A.M. Wilde(Amsterdam Neuroscience), Jeffrey A. Towbin(University of Tennessee Health Science Center), William J. McKenna(British Heart Foundation)
Cited by 4
Related Papers
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
|European Heart Journal|2015|3.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
|Circulation|1996|3.5k
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k